ResMed (RMD) Tops Q3 Views
RMD Hot Sheet
Financial Fact:Total operating expenses: 133.95M
Today's EPS Names:
IXYS, TARO, PAY, More
ResMed Inc. (NYSE: RMD) reports Q3 EPS of $0.57, ex-items, 7 cents better than the analyst estimate of $0.50. Revenue for the quarter was $247 million, which compares to the estimate of $239.50 million.
You May Also Be Interested In
- UPDATE: NetApp, Inc. (NTAP) Tops Q4 EPS by 3c; Guides Q1 Lower
- UPDATE: Bristow Group (BRS) Reports Better-Than-Expected Q4 Results; Offers FY13 Outlook
- American Eagle Outfitters (AEO) Tops Q1 EPS by 3c; Guides Q2, FY12
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
